NPRA

Directory | Consumers

Increase size

Reset to Default

Decrease size

NPRA Banner

New Publication: Reaksi Drug Safety News - Issue 3/2017

: Posted By Jauze; 20 July 2017; Hits: 13024

User Rating: 1 / 5

REAKSI Drug Safety News,

Issue 3/2017

Loperamide: Risk of Serious Cardiac Adverse Events with High Doses, Including Through Misuse
Thalidomide, Lenalidomide and Pomalidomide: Risk of Hepatitis B Reactivation, Herpes Zoster and Pulmonary Hypertension

Rating:

( 1 Rating )

National Pharmaceutical Regulatory Agency (NPRA)

Lot 36, Jalan Universiti (Jalan Prof Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.

Phone: +603-7883 5400

More Links

Privacy & Policy

More Links

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

NPRA Product Status

NPRA Product Status

Site Last Modified

Last Modified: Thursday 31 October 2024, 08:00:16.

Online Services

NPRA Support System

Online Public Engagement

Online Procurement Announcement